Shire plc’s Luxembourg, Inc. subsidiary has bid to acquire all shares of Movetis NV for approximately $561.4 million in cash. Movetis, a Belgium-based European specialty gastrointestinal (GI) company focuses on discovering, developing and commercializing new treatments for GI conditions with a high unmet medical need. The acquisition would expand Shire’s GI portfolio and its presence in Europe with the recently launched Resolor, a new chemical entity indicated for the treatment of chron...